MedTrace Logo

Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation

NCT04782050 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-04-25

No results posted yet for this study

Summary

Early screening and monitoring of chronic liver diseases in hepatology practice has become crucial. To achieve this goal, hepatology clinics need simple and available tools at the point-of-care to perform disease severity assessment. The objective of this study is to assess the performance of a new non-invasive ultrasound-based system for the assessment of liver fibrosis and steatosis severity, via ultrasound biomarkers such as tissue stiffness (correlated to fibrosis severity) and ultrasound tissue attenuation (correlated to steatosis extent).

Conditions

Interventions

DEVICE

Ultrasound liver assessment

The intervention consists in an ultrasound exam performed with the ultrasound medical device subject of the research.

Sponsors & Collaborators

  • University Hospital, Bordeaux

    collaborator OTHER

  • E-Scopics

    lead INDUSTRY

Principal Investigators

  • Victor de Lédinghen, MD · University Hospital, Bordeaux

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-15
Primary Completion
2022-08-29
Completion
2022-08-29

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04782050 on ClinicalTrials.gov